The program is a 48-week long program, divided into two phases, and consists of weekly teleconferences, lectures, and homework, plus two all-day remote group events. Participants in the C3i Program will develop a comprehensive set of core skills that will enable them to:
Evaluate whether a compelling unmet market need exists for their proposed solution
Assess whether there is a viable business opportunity that can be built to meet this need
Build a compelling pitch presentation to secure support from potential investors and other business partners.
The teams will be guided through a series of lectures and interactive exercises. They will pressure-test the commercial viability of ideas using universal business criteria as well as the unique requirements of medical commercialization. Participants also work with experienced business advisors and subject matter experts who provide insights into the market sector, intellectual property, regulatory, and reimbursement requirements specific for their projects.
The first 10 weeks, Phase 1 of the course, will focus on characterizing the unmet market need, identifying the customer and stakeholder segments, conducting customer and stakeholder interviews, and validating the business opportunity. The remaining weeks, Phase 2 of the course, will provide commercialization planning support, covering intellectual property strategy, regulatory and reimbursement requirements, risk assessment, milestone creation and valuation, and preparations for pitching to investors and/or strategic partners.
Sixteen teams will be selected to participate in Phase 1. Of these teams, 8 will be selected at the end of Phase 1 to continue to Phase 2.